Skip to content

Clinical trials

Observational Multiple Sclerosis, Relapsing-Remitting trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Phase: Observational Clear all

159 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20055
20065
20074
20089
200910
20103
20114
20128
20135
20143
20158
20165
20179
20189
20195
20205
202120
202210
202311
202412
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed105
Recruiting15
Unknown status15
Terminated9
Active, not recruiting7
Withdrawn3
Suspended2
Not yet recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen19
Merck KGaA, Darmstadt, Germany17
Bayer11
Novartis Pharmaceuticals6
Bristol-Myers Squibb4
Heinrich-Heine University, Duesseldorf3
Hoffmann-La Roche3
Kessler Foundation3
McGill University3
University Hospital, Basel, Switzerland3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting159
Multiple Sclerosis82
Multiple Sclerosis, Chronic Progressive27
Fatigue5
Disease Progression3
Inflammation3
Neuromyelitis Optica3
Anxiety Disorders2
Arthritis, Rheumatoid2
Cognitive Dysfunction2

Trials

Showing 76 to 100 of 159. Each trial links to its page on Pharma Observatory.

59 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.